Literature DB >> 22796118

Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model.

Helen M Nugent1, Yin-Shan Ng, Desmond White, Adam Groothius, Glenn Kanner, Elazer R Edelman.   

Abstract

OBJECTIVE: High restenosis rates are a limitation of peripheral vascular interventions. Previous studies have shown that surgical implantation of a tissue-engineered endothelium onto the adventitia surface of injured vessels regulates vascular repair. In the present study, we developed a particulate formulation of tissue-engineered endothelium and a method to deliver the formulation perivascular to injured blood vessels using a percutaneous, minimally invasive technique.
METHODS: Stainless steel stents were implanted in 18 balloon-injured femoral arteries of nine domestic swine, followed by ultrasound-guided percutaneous perivascular injection of gelatin particles containing cultured allogeneic porcine aortic endothelial cells (PAE). Controls received injections of empty particles (matrix) or no perivascular injection (sham) after stent deployment. Animals were sacrificed after 90 days.
RESULTS: Angiographic analysis revealed a significantly greater lumen diameter in the stented segments of arteries treated with PAE/matrix (4.72 ± 0.12 mm) compared with matrix (4.01 ± 0.20 mm) or sham (4.03 ± 0.16 mm) controls (P < .05). Similarly, histologic analysis revealed that PAE/matrix-treated arteries had the greatest lumen area (20.4 ± 0.7 mm(2); P < .05) compared with controls (16.1 ± 0.9 mm(2) and 17.1 ± 1.0 mm(2) for sham and matrix controls, respectively) and the smallest intimal area (3.3 ± 0.4 mm(2); P < .05) compared with controls (6.2 ± 0.5 mm(2) and 4.4 ± 0.5 mm(2) for sham and matrix controls, respectively). Overall, PAE-treated arteries had a 33% to 50% decrease in percent occlusion (P < .05) compared with controls. Histopathological analysis revealed fewer leukocytes present in the intima in the PAE/matrix group compared with control groups, suggesting that the biological effects were in part due to inhibition of the inflammatory phase of the vascular response to injury.
CONCLUSIONS: Minimally invasive, perivascular delivery of PAE/matrix to stented arteries was performed safely using ultrasound-guided percutaneous injections and significantly decreased stenosis. Application at the time of or subsequent to peripheral interventions may decrease clinical restenosis rates.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22796118      PMCID: PMC3762489          DOI: 10.1016/j.jvs.2012.03.002

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  36 in total

Review 1.  Pathology of in-stent restenosis.

Authors:  R Virmani; A Farb
Journal:  Curr Opin Lipidol       Date:  1999-12       Impact factor: 4.776

2.  PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study.

Authors:  M Cejna; S Thurnher; H Illiasch; W Horvath; P Waldenberger; K Hornik; J Lammer
Journal:  J Vasc Interv Radiol       Date:  2001-01       Impact factor: 3.464

3.  Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury.

Authors:  H M Nugent; E R Edelman
Journal:  J Surg Res       Date:  2001-08       Impact factor: 2.192

4.  Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions.

Authors:  J Grimm; S Müller-Hülsbeck; T Jahnke; C Hilbert; J Brossmann; M Heller
Journal:  J Vasc Interv Radiol       Date:  2001-08       Impact factor: 3.464

5.  Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.

Authors:  E Minar; B Pokrajac; T Maca; R Ahmadi; C Fellner; M Mittlböck; W Seitz; R Wolfram; R Pötter
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

Review 6.  The reactive adventitia: fibroblast oxidase in vascular function.

Authors:  Federico E Rey; Patrick J Pagano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

7.  The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.

Authors:  Heleen M M van Beusekom; Gökhan Ertaş; Oana Sorop; Patrick W Serruys; Willem J van der Giessen
Journal:  Catheter Cardiovasc Interv       Date:  2011-08-10       Impact factor: 2.692

8.  Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.

Authors:  A Farb; P F Heller; S Shroff; L Cheng; F D Kolodgie; A J Carter; D S Scott; J Froehlich; R Virmani
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

9.  Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia.

Authors:  M A Nugent; H M Nugent; R V Iozzo; K Sanchack; E R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

10.  Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig.

Authors:  Helen M Nugent; Adam Groothuis; Philip Seifert; J Luis Guerraro; Mark Nedelman; T Mohanakumar; Elazer R Edelman
Journal:  J Vasc Res       Date:  2002 Nov-Dec       Impact factor: 1.934

View more
  4 in total

1.  The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits.

Authors:  Xiang-Jun Wu; Zhao-Qiang Dong; Qing-Hua Lu
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  Finite element modeling of a novel self-expanding endovascular stent method in treatment of aortic aneurysms.

Authors:  Mark C Arokiaraj; Igor F Palacios
Journal:  Sci Rep       Date:  2014-01-10       Impact factor: 4.379

3.  A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.

Authors:  Laura Paneghetti; Yin-Shan Eric Ng
Journal:  Vasc Cell       Date:  2016-05-11

4.  Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study.

Authors:  Junhui Shen; Ru Xiao; Jeffrey Bair; Fang Wang; Luk H Vandenberghe; Darlene Dartt; Petr Baranov; Yin Shan Eric Ng
Journal:  Cell Death Dis       Date:  2018-10-03       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.